Document is current
Any future updates will be listed below
-
Authors
Scott, Jan
Hidalgo-Mazzei, Diego
Strawbridge, Rebecca
Young, Allan
Resche-Rigon, Matthieu
Etain, Bruno
Andreassen, Ole A.
Bauer, Michael
Bennabi, Djamila
Blamire, Andrew M.
Boumezbeur, Fawzi
Brambilla, Paolo
Cattane, Nadia
Cattaneo, Annamaria
Chupin, Marie
Coello, Klara
Cointepas, Yann
Colom, Francesc
Cousins, David A.
Dubertret, Caroline
Duchesnay, Edouard
Ferro, Adele
Garcia-Estela, Aitana
Goikolea, Jose
Grigis, Antoine
Haffen, Emmanuel
Høegh, Margrethe C.
Jakobsen, Petter
Kalman, Janos L.
Kessing, Lars V.
Klohn-Saghatolislam, Farah
Lagerberg, Trine V.
Landén, Mikael
Lewitzka, Ute
Lutticke, Ashley
Mazer, Nicolas
Mazzelli, Monica
Mora, Cristina
Muller, Thorsten
Mur-Mila, Estanislao
Oedegaard, Ketil Joachim
Oltedal, Leif
Pålsson, Erik
Papadopoulos Orfanos, Dimitri
Papiol, Sergi
Perez-Sola, Victor
Reif, Andreas
Ritter, Philipp
Rossi, Roberto
Schulze, Thomas
Senner, Fanny
Smith, Fiona E.
Squarcina, Letizia
Steen, Nils Eiel
Thelwall, Pete E.
Varo, Cristina
Vieta, Eduard
Vinberg, Maj
Wessa, Michele
Westlye, Lars T.
Bellivier, Frank http://orcid.org/0000-0002-3660-6640
-
Funding
Funding for this research was provided by:
H2020 Research and Innovation Program (754907)
- License Information
-
More Information
Article History
Received: 11 March 2019
Accepted: 24 July 2019
First Online: 25 September 2019
Ethics/registration
: The protocol was approved by the French Ethical Committee (CPP no 2, Paris) on December 7, 2018 and registered under the number 18.08.02.40026 RiPH 2.
: Not applicable.
: FB is the Principal Investigator for R-LiNK and all authors are researchers involved in funded R-LiNK study. JS is a Visiting Professor at Diderot University, Paris and an Honorary Professor at Kings College, London. AY declares paid lectures and advisory boards for the following companies with drugs used in affective and related disorders: AstraZeneca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, and Janssen. He is a paid consultant to Johnson & Johnson, is lead Investigator for Embolden Study (AstraZeneca), BCI Neuroplasticity study and a pharma sponsored Aripiprazole in Mania study. His institution has received funding for investigator-initiated studies from AstraZeneca, Eli Lilly, Lundbeck, Wyeth, and Janssen. D.A. Cousins, F.E. Smith, P.E. Thelwall and A.M. Blamire are conducting the Bipolar Lithium Imaging and Spectroscopy Study (BLISS; Medical Research Council Clinician Scientist Award to DAC—BH135495), a cross sectional evaluation of the effects of lithium on brain structure and composition with respect to response. This study led to the development of the <sup>7</sup>Li-MRI technique used in the R-LiNK study; the authors report no competing interests with respect to this and have no other declarations. Competing interests and declarations for other co-authors available upon request.
